How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?

MLA

Dong, Kathryn A., and Katherine M. Duthie. “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” AMA Journal of Ethics, vol. 26, no. 7, July 2024, pp. 512–19. EBSCOhost, https://doi.org/10.1001/amajethics.2024.512.

APA

Dong, K. A., & Duthie, K. M. (2024). How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? AMA Journal of Ethics, 26(7), 512–519. https://doi.org/10.1001/amajethics.2024.512

Chicago

Dong, Kathryn A., and Katherine M. Duthie. 2024. “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” AMA Journal of Ethics 26 (7): 512–19. doi:10.1001/amajethics.2024.512.